Loading…
Lobbying Spend
—
Filings
5
Firms Hired
1
Active Period
2005–2006
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
A bill to suspend temporarily the duty on gemifloxacin, gemifloxacin mesylate, and gemifloxacin mesylate sesquihydrate.
2006 · year_end · Firm: ML STRATEGIES, LLC
H.R 4944 Miscellaneous Trade and Technical Corrections Act of 2006 regarding tariff and trade issues related to pharmaceuticals H.R.2380, S.1617 and S.3358 regarding Miscellaneous Trade and Technical Corrections Act of 2006
Client expense: — · Firm income: $60,000
Matched citations: S.1617
A bill to suspend temporarily the duty on gemifloxacin, gemifloxacin mesylate, and gemifloxacin mesylate sesquihydrate.
2006 · year_end · Firm: ML STRATEGIES, LLC
H.R.4944 Miscellaneous Trade and Technical Corrections Act of 2006 regarding tariff and trade issues related to pharmaceuticals H.R.2380, S.1617 and S.3358 regarding Miscellaneous Trade and Technical Corrections Act of 2006
Client expense: — · Firm income: $60,000
Matched citations: S.1617
A bill to suspend temporarily the duty on gemifloxacin, gemifloxacin mesylate, and gemifloxacin mesylate sesquihydrate.
2006 · year_end · Firm: ML STRATEGIES, LLC
H.R.4944 Miscellaneous Trade and Technical Corrections Act of 2006 regarding tariff and trade issues related to pharmaceuticals H.R.2380, S.1617 and S.3358 regarding Miscellaneous Trade and Technical Corrections Act of 2006
Client expense: — · Firm income: $60,000
Matched citations: S.1617
A bill to suspend temporarily the duty on gemifloxacin, gemifloxacin mesylate, and gemifloxacin mesylate sesquihydrate.
2006 · year_end · Firm: ML STRATEGIES, LLC
H.R 4944 Miscellaneous Trade and Technical Corrections Act of 2006 regarding tariff and trade issues related to pharmaceuticals H.R.2380, S.1617 and S.3358 regarding Miscellaneous Trade and Technical Corrections Act of 2006
Client expense: — · Firm income: $60,000
Matched citations: S.3358
A bill to suspend temporarily the duty on gemifloxacin, gemifloxacin mesylate, and gemifloxacin mesylate sesquihydrate.
2006 · year_end · Firm: ML STRATEGIES, LLC
H.R.4944 Miscellaneous Trade and Technical Corrections Act of 2006 regarding tariff and trade issues related to pharmaceuticals H.R.2380, S.1617 and S.3358 regarding Miscellaneous Trade and Technical Corrections Act of 2006
Client expense: — · Firm income: $60,000
Matched citations: S.3358
A bill to suspend temporarily the duty on gemifloxacin, gemifloxacin mesylate, and gemifloxacin mesylate sesquihydrate.
2006 · year_end · Firm: ML STRATEGIES, LLC
H.R.4944 Miscellaneous Trade and Technical Corrections Act of 2006 regarding tariff and trade issues related to pharmaceuticals H.R.2380, S.1617 and S.3358 regarding Miscellaneous Trade and Technical Corrections Act of 2006
Client expense: — · Firm income: $60,000
Matched citations: S.3358
Source: Senate LDA